A Novel Nanobody as Therapeutics Target for EGFR-Positive Colorectal Cancer Therapy: Exploring the Effects of the Nanobody on SW480 Cells Using Proteomics Approach

Researchers determined the effect of cell-penetrable nanobody on cell viability and proteomic profile in epidermal growth factor receptor (EGFR)-positive human colorectal cancer cell lines.